Coherence Neuro

Coherence Neuro

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://coherenceneuro.com

Last Round

Seed

Nov 4, 2025

Total Funding Raised

$12.34M

Momentum Score

50 /100

Company Overview

Coherence Neuro is a medical technology company that designs therapeutic neurotechnology to manage cancer from inside the body.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Precision Medicine, Biotechnology, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

brain-computer interfaceBCIcancer treatmentimplantable medical deviceglioblastoma treatmentbrain implantbioelectronic medicineneurotechnologyneuromodulationclosed-loop therapyelectroceuticalstumor treating fieldsprecision medicinesoftware as a therapydigital therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Coherence Neuro Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Coherence Neuro Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedNov 4, 2025
Pre SeedMar 13, 2023
GrantAug 3, 2022

Key People

Founding team and executive leadership

Elise Jenkins

Co-Founder, CTO

Founding Team

Ben Woodington

CEO Co-Founder

Founding Team

Coherence Neuro Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Grew 42% QoQ from 19 to 27 employees.

Coherence Neuro Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Coherence Neuro Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Coherence Neuro's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range27
Year Founded2022
Last FundingNov 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.